Hledání článků
Filtry
Royal V, Leung N, Troyanov S, et al. Clinicopathological predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study. Blood 2020;135:1833–1846.
Rondeau E, Scully M, Ariceta G, et al.; 311 Study Group. The long‑acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment. Kidney Int 2020;97:1287–1296.
Steubl D, Schneider MP, Meiselbach H, et al. Association of serum uromodulin with death, cardiovascular events, and kidney failure in CKD. Clin J Am Soc Nephrol 2020;15:616–624.
Curry JN, Saurette M, Askari M, et al. Claudin‑2 deficiency associates with hypercalciuria in mice and human kidney stone disease. J Clin Invest 2020;130:1948–1960.
STARRT‑AKI Investigators, et al. Timing of Initiation of Renal‑Replacement Therapy in Acute Kidney Injury. N Engl J Med 2020;383:240–251.
De Rosa M, Rocha AS, De Rosa G, et al. Low‑Grade Proteinuria Does Not Exclude Significant Kidney Injury in Lupus Nephritis. Kidney Int Rep 2020;5:1066–1068.
Voora S, Adey DB. Management of kidney transplant recipients by general nephrologists: Core Curriculum 2019. Am J Kidney Dis 2019;73:866–879.
Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020;75:1334–1357.
Chimenti C, Nencini P, Pieruzzi F, et al. The GALA project: practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts. Orphanet J Rare Dis 2020;15:86. Published 2020 Apr 7. doi: 10.1186/s13023‑020‑1318‑8
Verma S, Ji Q, Bhatt DL, et al. Association between uric acid levels and cardio‑renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‑REG OUTCOME. Diabetes Obes Metab 2020 Feb 6. doi: 10.1111/dom.13991. Online ahead of print